Orthofix introduced its Biologics Surgeon Advisory Board which includes seven spine surgeons, according to a Feb. 4 news release.
The board includes experts in orthopedic spine and spinal neurosurgery, and they were chosen based on their clinical experience, leadership in the spine community and recognition of the importance of biologics in spinal fusions. The group will support Orthofix’s scientific foundation and provide insights to support the biologics portfolio.
The surgeons named to the board are:
Andrew Chung, DO
Raymond Hah, MD
Phillip Louie, MD
Emmanuel Menga, MD
J. Adair Prall, MD
Harvinder Sandhu, MD
Jason Savage, MD
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.